4-methoxyamphetamine has been researched along with Hepatocellular Carcinoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Alebrahim, M; Bohorquez, H; Cannon, RM; Hoffman, JRH; Lee, DD; McMaster, WG; Montenovo, MI; Nassar, A; Neidlinger, N; Sasaki, K; Sellers, MT; Selvaggi, G; Shah, AS | 1 |
| Feng, W; Han, Z; Hu, R; Huang, Q; Li, J; Lv, M; Ma, M; Sun, X; Zhang, W; Zhong, X; Zhou, X | 1 |
| Dodge, JL; Grab, JD; Mehta, N; Roll, G; Silverstein, J; Yao, FY | 1 |
| Diaz, A; Hyer, JM; Pawlik, TM; Rice, DR | 1 |
| Eckhoff, DE; Fleishman, A; Haque, OJ; Khwaja, K; Roth, EM | 1 |
| Alconchel, F; Cascales, P; Febrero, B; Ferreras, D; González, MR; Martinez, M; Martinez-Insfran, LA; Parrilla, P; Ramirez, P; Robles, R; Sanchez-Bueno, F | 1 |
| Beck, G; Chandok, N; Croome, KP; Hernandez-Alejandro, R; Marotta, P; Wall, W | 1 |
| Burns, JM; Croome, KP; Harnois, DM; Lee, DD; Musto, K; Nguyen, JH; Paz, D; Perry, DK; Taner, CB | 1 |
| Croome, KP; Keaveny, AP; Lee, DD; Taner, CB | 1 |
| Alonso, P; Barneo, L; Cadahía, V; García-Bernardo, C; González-Diéguez, ML; González-Pinto, IM; Miyar de León, A; Rodríguez, M; Vázquez, L | 1 |
| Abdel-Dayem, H; Abdo, AA; Al Hamoudi, W; Al Saghier, A; Al Saghier, M; Al Sebayel, M; Al Sofayan, M; Aljedai, A; Allam, N; El Sheikh, Y; Helmy, A; Kamel, Y; Kenetman, NM; Khalaf, H | 1 |
| Chen, CY; Cheng, SY; Chiu, TY; Dy, S; Fang, PH | 1 |
| ABELMANN, WH; DAVIDSON, CS; JANDL, JH; MACDONALD, RA | 1 |
| BRUNO, MS; OBER, WB | 1 |
14 other study(ies) available for 4-methoxyamphetamine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Early United States experience with liver donation after circulatory determination of death using thoraco-abdominal normothermic regional perfusion: A multi-institutional observational study.
Topics: Adult; Carcinoma, Hepatocellular; Death; Graft Survival; Humans; Kidney Transplantation; Liver Neoplasms; Middle Aged; Organ Preservation; Perfusion; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors; United States | 2022 |
FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma.
Topics: Cadherins; Carcinoma, Hepatocellular; Death; Humans; Leukocytes, Mononuclear; Liver Neoplasms; MicroRNAs; Prognosis; Tumor Suppressor Proteins | 2023 |
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Topics: Carcinoma, Hepatocellular; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2020 |
End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Death; Ethnicity; Health Expenditures; Hospices; Humans; Liver Neoplasms; Medicare; Minority Groups; United States | 2021 |
Long-Term Outcomes of Early Experience in Donation After Circulatory Death Liver Transplantation: Outcomes at 10 Years.
Topics: Adult; Brain Death; Carcinoma, Hepatocellular; Death; End Stage Liver Disease; Female; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2021 |
Early Outcomes of Liver Transplantation Using Donors After Circulatory Death in Patients With Hepatocellular Carcinoma: A Comparative Study.
Topics: Adult; Carcinoma, Hepatocellular; Death; Female; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Time Factors; Tissue Donors; Treatment Outcome | 2019 |
Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
Topics: Adult; Aged; Allografts; Carcinoma, Hepatocellular; Death; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Tissue Donors | 2013 |
The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma.
Topics: Adult; Aged; Allografts; Brain Death; Carcinoma, Hepatocellular; Death; Donor Selection; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2015 |
Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
Topics: Adult; Age Factors; Aged; Body Mass Index; Brain Death; Carcinoma, Hepatocellular; Cold Ischemia; Databases, Factual; Death; Donor Selection; Female; Graft Survival; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors; United States | 2016 |
Exclusions and deaths on the liver transplant waiting list.
Topics: Adult; Carcinoma, Hepatocellular; Death; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Probability; Spain; Survival Rate; Time Factors; Waiting Lists | 2010 |
Clinical outcomes for Saudi and Egyptian patients receiving deceased donor liver transplantation in China.
Topics: Adult; Aged; Biliary Tract Diseases; Carcinoma, Hepatocellular; China; Constriction, Pathologic; Death; Egypt; Female; Graft Survival; Hepatitis B; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Male; Medical Tourism; Middle Aged; Postoperative Complications; Retrospective Studies; Saudi Arabia; Tissue Donors; Treatment Outcome | 2010 |
Evaluation of inpatient multidisciplinary palliative care unit on terminally ill cancer patients from providers' perspectives: a propensity score analysis.
Topics: Adult; Carcinoma, Hepatocellular; Case-Control Studies; Death; Female; Hospice Care; Hospital Units; Humans; Inpatients; Interdisciplinary Communication; Linear Models; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Palliative Care; Patient Admission; Patient Care Team; Prospective Studies; Sex Factors; Taiwan; Terminally Ill; Tertiary Care Centers | 2013 |
HEMOCHROMATOSIS TERMINATING IN POLYCYTHEMIA AND HEPATOMA, WITH OBSERVATIONS ON THE NATURAL HISTORY OF HEMOCHROMATOSIS.
Topics: Alcoholism; Biopsy; Carcinoma, Hepatocellular; Death; Hemochromatosis; Histological Techniques; Humans; Liver Neoplasms; Pathology; Polycythemia | 1963 |
JAUNDICE, ASCITES, AND DEATH.
Topics: Alcoholism; Ascites; Carcinoma, Hepatocellular; Death; Humans; Jaundice; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Nephrosis; Pathology; Pituitary Gland; Splenomegaly | 1964 |